Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia

Research output: Contribution to journalArticleAcademicpeer-review

76 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)627-629
Number of pages3
JournalLeukemia
Volume23
Issue number3
DOIs
Publication statusPublished - 2009

Research programs

  • EMC MGC-02-96-01
  • EMC MM-02-41-03

Cite this